UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000027887
Receipt number R000031949
Scientific Title Multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer
Date of disclosure of the study information 2017/07/26
Last modified on 2022/12/26 11:16:51

No. Disposal Last modified on Item of update
1 Insert 2017/06/23 11:13:57
2 Update 2017/06/23 15:40:20 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
3 Update 2017/06/26 08:39:41 Target sample size
4 Update 2017/06/26 08:40:19 Date of disclosure of the study information
5 Update 2017/10/03 09:00:26 Anticipated trial start date
6 Update 2017/12/21 13:53:50 Recruitment status
7 Update 2017/12/21 13:54:15 Anticipated trial start date
8 Update 2017/12/21 15:49:23 Classification by specialty
9 Update 2018/03/01 13:22:44 Institutions
10 Update 2018/03/26 08:37:46 Institutions
11 Update 2018/06/05 15:32:30 Public title
12 Update 2018/12/27 15:06:48 Target sample size
13 Update 2019/06/24 07:25:56 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
Zip code
Address
Address

Last name of contact person

Last name of contact person
Zip code
Address
Address
Address1
Organization
Organization
Address
Address
Tel
Email
14 Update 2019/06/24 07:28:39 Date of IRB
Last follow-up date
15 Update 2019/08/01 13:57:12 Recruitment status
16 Update 2019/12/25 10:26:53 Number of participants that the trial has enrolled
17 Update 2021/06/25 09:19:29 Last follow-up date
18 Update 2022/06/27 09:05:41 Last follow-up date
Date of closure to data entry
19 Update 2022/06/27 09:05:41 Last follow-up date
Date of closure to data entry
20 Update 2022/12/26 11:16:51 Recruitment status
Date trial data considered complete
Date analysis concluded